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Abstract: Maternal recognition of pregnancy (MRP) in the mare is not well defined. In a non-pregnant
mare, prostaglandin F2α (PGF) is released on day 14 post-ovulation (PO) to cause luteal regression,
resulting in loss of progesterone production. Equine MRP occurs prior to day 14 to halt PGF
production. Studies have failed to identify a gene candidate for MRP, so attention has turned to small,
non-coding RNAs. The objective of this study was to evaluate small RNA (<200 nucleotides) content
in endometrium during MRP. Mares were used in a cross-over design with each having a pregnant
and non-mated cycle. Each mare was randomly assigned to collection day 11 or 13 PO (n = 3/day)
and endometrial biopsies were obtained. Total RNA was isolated and sequencing libraries were
prepared using a small RNA library preparation kit and sequenced on a HiSeq 2000. EquCab3 was
used as the reference genome and DESeq2 was used for statistical analysis. On day 11, 419 ncRNAs,
representing miRNA, snRNA, snoRNA, scaRNA, and vaultRNA, were different between pregnancy
statuses, but none on day 13. Equine endometrial ncRNAs with unknown structure and function
were also identified. This study is the first to describe ncRNA transcriptome in equine endometrium.
Identifying targets of these ncRNAs could lead to determining MRP.
Keywords: equine; pregnancy; maternal recognition of pregnancy; embryo; non-coding RNA;
endometrium
1. Introduction
Early pregnancy in the mare is a process that is still not well defined. Specifically, the signal for
maternal recognition of pregnancy (MRP) remains a mystery. The equine embryo does not attach
to the endometrium until approximately day 35 post-ovulation (PO). Therefore, the communication
between the embryo and the endometrium occurs without any attachment of the two. During the estrous
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cycle, if the endometrium fails to recognize a viable embryo, it produces prostaglandin F2α (PGF)
on day 14 PO to cause regression of the corpus luteum (CL) [1,2]. The corpus luteum is necessary
during pregnancy to produce progesterone. There may be the presence of a conceptus, but this does
not necessarily mean that the mare will be pregnant or undergo maternal recognition of pregnancy
(such as with concomitant inflammation/aneuploidy) [3].
The hormonal profile of both pregnant and non-pregnant mares is the same until day 14 PO [2].
In the non-pregnant mare, when no embryo is recognized, oxytocin is produced by both the posterior
pituitary gland and endometrium. Endometrial receptors bind the oxytocin, which ultimately causes
the production and release of more oxytocin, resulting in the production of PGF [1].
In a pregnant mare, fertilization occurs in the oviduct and the conceptus enters the uterus on
day 6 by releasing prostaglandin E2 (PGE) around day 4 [4]. When the embryo enters the uterus,
it is surrounded by an acellular glycoprotein capsule, a feature that is unique to equine and rabbit
embryos [5,6]. At this point, the embryo is mobilized throughout the entire uterus by uterine
contractions [7]. This mobility is necessary in order to signal MRP [8,9]. Maximum mobility occurs
between days 11–14, then ceases movement by day 16 when the embryo becomes fixed in a single
location, but does not attach or invade [7]. Maternal recognition of pregnancy occurs during the time
frame when the embryo is most mobile (days 11–14) [10]. It is thought that this embryo mobility
impacts focal adhesion molecules on the endometrium, leading to MRP [11,12]. If a mare is pregnant,
MRP occurs, and the endometrium will not produce or release PGF, therefore allowing the CL and its
progesterone production to be sustained, indicating that MRP in the mare is antiluteolytic [7,10,13].
Previous experiments have tested the signals for MRP in other species, such as estradiol (pigs)
and Interferon tau (cows), on the mare, but these result in no changes in equine luteal function [14,15].
Studies have progressed to evaluating gene expression within the endometrium, but no obvious gene
candidates have been uncovered [11,16–18]. Recent studies in our laboratory have identified that
the content, specifically miRNAs, of serum exosomes differ between pregnant and non-pregnant mares
during MRP [19]. The source and function of these miRNAs are unknown, but due to their difference
based on pregnancy status it could be hypothesized that they are of endometrial origin. A more recent
study in our lab utilized RNA sequencing to evaluate coding RNA in equine endometrium during
maternal recognition of pregnancy based upon pregnancy status [12]. An interesting result was that
what appeared to be a large number of transcripts underwent alternative splicing during this time
frame. These studies raised interest in evaluating the small non-coding RNA content in endometrium
during MRP.
Small non-coding RNAs (ncRNAs), which are less than 200 nucleotides long, do not code for protein
and are typically involved in the regulation of RNA processing and function [20]. We hypothesized
that endometrial ncRNA content would be altered in relation to pregnancy status. The objective of
this study was to identify small ncRNAs, focusing mainly on miRNAs, and their temporal expression
changes in equine endometrium during maternal recognition of pregnancy via RNA sequencing.
2. Materials and Methods
2.1. Care and Management of Mares
Horse use was approved by the Colorado State University Institutional Animal Care and Use
Committee. Mares (n = 6 total) were housed in group pens at the Colorado State University Bud
and Jo Adams Equine Reproduction Laboratory (Fort Collins, CO, USA). Horses were maintained on
a dry lot and fed a grass–alfalfa hay mix with free choice mineral and salt supplement. Mares were
used in a paired, cross-over design where each mare had a pregnant and non-pregnant (non-mated)
cycle for their specified collection day. Mares were randomly assigned to a collection day (day 11 or 13
post-ovulation, n = 3 per day). Mares were monitored via transrectal palpation and ultrasonography
to track their follicular development every other day. To obtain samples from a pregnant mare, once
a follicle reached 35 mm in diameter, or larger, the mare was inseminated with at least 500 × 106
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progressively motile sperm from a stallion. Different stallions were utilized, but all with proven fertility.
Mares were then monitored via transrectal ultrasonography every day and inseminated every other
day until ovulation (day 0).
On the mare’s assigned day, she was evaluated via transrectal ultrasonography to confirm
pregnancy status by visualization of an embryonic vesicle. Endometrial samples were obtained via
a trans-cervical biopsy punch, followed by a terminal uterine lavage to again confirm pregnancy status [21].
After endometrial sample collection, the mare received a luteolytic dose of PGF (Estrumate, Merck Animal
Health, 250 mcg per dose) and the subsequent estrous cycle was used for the non-pregnant (non-mated)
cycle. After endometrial sample collection, the sample was rinsed in DPBS/Modified 1X (Hyclone
Laboratories, Logan, UT) and stored at −80 ◦C until further analysis.
2.2. RNA Isolation and Quantification
Total RNA from the endometrium was extracted using the mirVana miRNA Isolation kit
(Invitrogen, Carlsbad, CA, USA) at the University of California-Davis. Briefly, samples were homogenized
in lysis/binding buffer. MiRNA homogenate additive was added to the lysate and incubated for 10 min
on ice. Acid-Phenol:Chloroform was added to the lysate, vortexed, and centrifuged at 10,000 × g for
5 min. The sample was then separated into three distinct phases (RNA, DNA, and protein). The top,
aqueous RNA phase was transferred to a new 1.7 mL tube for RNA purification. Ethanol was added to
the RNA phase solution and then passed through a filter provided by Invitrogen. The filters were then
washed with miRNA wash solution and eluted in the Elution Solution. RNA purity and quantification
were assessed using the NanoDrop Spectrophotometer ND-1000 (Thermo Scientific, Wilmington, DE).
Samples were used for PCR analysis if they had 260/280 and 260/230 values above 1.7.
2.3. RNA Sequencing
Libraries were prepared at the University of California-Davis using the Illumina TruSeq Small
RNA Library Preparation kit (Illumina, San Diego, CA, USA) and 1 µg of Total RNA from each sample,
following the manufacturer’s protocol. Briefly, adapters were ligated, and samples were reverse
transcribed to cDNA. Each sample was amplified with a specified barcoded PCR primer for identification
purposes. Samples were pooled and run out on a DNA gel, and the region of 147–157 nucleotides was
excised and isolated from the gel. This represented the small RNA that was to be sequenced. After gel
extraction, the samples were suspended in 10 mM Tris-HCl, pH 8.5. Libraries were evaluated for
quality with a Bioanalyzer (Agilent, Santa Clara, CA) and sent to the University of California-Berkeley
for sequencing using a HiSeq 2000 sequence analyzer (Illumina, San Diego, CA, USA). Sequences are
available in the NCBI sequence read archive under BioProject PRJNA545717.
2.4. Bioinformatic Analysis
Bioinformatic analysis was performed on the Galaxy web platform [22] and used the public
server at usegalaxy.org. Sequence quality was assessed by FastQC, and results were aggregated
and evaluated using MultiQC [23,24]. Trimmomatic was utilized to remove the adapter sequence
and low-quality sequence [25]. Reads were aligned to EquCab3.0 ncRNA FASTA from Ensembl
(version 96) and transcripts quantified using Salmon [26–28]. Count data (number of reads from
Salmon) were analyzed within each day, comparing samples from pregnant mares to non-pregnant
mares utilizing DESeq2 within R [29]. To be considered for analysis, reads were present in at least two
out of the three replicates in at least one of the two groups (P + or NP). Data were normalized internally
using DESeq2’s median of ratios method. Benjamini–Hochberg false discovery rate adjustment was
used. Significance was assessed at p ≤ 0.05.
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3. Results
3.1. Sequencing Results
Quality control assessment indicated that reads had a high adapter content. Based upon these
results, the 50 base pair reads were trimmed to 23 base pairs for all samples. Samples generated,
on average, 10,288,100 reads (ranging from 2,713,658 to 17,261,023).
3.2. Small RNA Transcript Analysis
Overall, there were 8370 non-coding RNAs identified in the equine endometrium on day 11
and 3984 on day 13. Of the ncRNA identified in the endometrium, 3653 were present on both days 11
and 13. On day 11, there were 419 differentially expressed small non-coding RNAs (ncRNAs; p ≤ 0.05)
between samples from pregnant and non-pregnant mares. Only 16 of these ncRNAs were more abundant
in samples from pregnant mares (3.8%), and 403 were more abundant in samples from non-pregnant
mares (96.2%). These 419 ncRNAs represented multiple families of ncRNA, including miRNA
(microRNA), snRNA (small nuclear RNA), snoRNA (small nucleolar RNA), and scaRNA (small Cajal
body-specific RNA; Figure 1). Only 123 transcripts were identified as specific ncRNAs; the remaining
296 were identified as ncRNAs in the horse, but with unknown structure or function by Ensembl
(version 96). The largest family of known ncRNA represented in this study was our focus, miRNA
(58 out of 419 differentially expressed ncRNA). Table 1 contains the top 20 most significant known
ncRNA in our dataset. Supplemental Table S1 contains the complete list of differentially expressed
ncRNAs on day 11.
Table 1. Top 20 differentially expressed non-coding RNA in the endometrium on day 11 with
known structure.




Average Day 11 p-Value
ENSECAT00000029757 U109 snoRNA 1 71,765 2.1E-07
ENSECAT00000028132 U1 snRNA 0 21,351 5.4E-07
ENSECAT00000032319 eca-mir-9109 miRNA 9 15,762 6.3E-07
ENSECAT00000055936 eca-mir-8986b miRNA 448 0 1.1E-06
ENSECAT00000027602 eca-mir-323 miRNA 11 39,904 1.2E-06
ENSECAT00000027815 SNORA69 snoRNA 49 36,277 6.7E-06
ENSECAT00000028354 MIR15B miRNA 81 39,222 9.2E-06
ENSECAT00000032694 U6 snRNA 0 4866 1.5E-05
ENSECAT00000027790 MIR137 miRNA 2 2916 1.6E-05
ENSECAT00000027318 SNORA2B snoRNA 4 5177 1.7E-05
ENSECAT00000028446 SNORD65 snoRNA 20 9278 1.7E-05
ENSECAT00000029752 SCARNA17 scaRNA 16 5915 2.3E-05
ENSECAT00000029923 eca-mir-9080 miRNA 13 5718 4.4E-05
ENSECAT00000028257 SNORA71 snoRNA 22 8449 4.4E-05
ENSECAT00000027964 eca-mir-652 miRNA 24 9678 4.4E-05
ENSECAT00000028540 SNORA12 snoRNA 2 1924 4.6E-05
ENSECAT00000028054 MIR1306 miRNA 15 4741 5.1E-05
ENSECAT00000027873 eca-mir-582 miRNA 3 2342 1.0E-04
ENSECAT00000028318 SNORA36A snoRNA 48 12,262 1.3E-04
ENSECAT00000027279 SNORD59A snoRNA 246 38,612 1.8E-04
This table breaks down the significant (p ≤ 0.05) ncRNA with known structure and function in the endometrium on
day 11 ranked based upon significance. The average represents the average number of reads determined during
Salmon analysis. Non-coding RNA names bolded indicate they were more highly expressed in samples from
pregnant mares.
Of the 419 significant differentially expressed ncRNAs on day 11, 7 were present only in samples
from pregnant mares (2 miRNAs and 5 unknown ncRNAs) and 175 were present only in samples
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from non-pregnant mares (2 miRNAs, 2 snRNAs, 1 snoRNA, and 170 unknown ncRNAs). On day 13,
there were no differences in ncRNA expression between the two sample groups.
This table breaks down the significant (p ≤ 0.05) ncRNAs with known structure and function
in the endometrium on day 11 ranked based upon significance. The average represents the average
number of reads determined during Salmon analysis. Non-coding RNA names bolded indicate they
were more highly expressed in samples from pregnant mares.
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4. Discussion
These are the first sequence data to investigate small ncRNA in equine endometrium during
maternal recognition of pregnancy. Non-coding RNA transcripts, like miRNA, were once considered
part of the genome’s “junk” DNA, which was believed to be non-functional in terms of transcription.
Even though they do not code for proteins, miRNAs have critical roles as post-transcriptional regulators
of protein-coding gene expression impacting the mRNA abundance of up to 60% of protein-coding
genes in mammals [30]. This study identified many different families of ncRNA, including miRNA,
snRNA, and snoRNA. Each of these families plays an essential role in the post-transcriptional regulation
of gene expression.
MicroRNAs are short single-stranded RNAs, approximately 22 nucleotides in length [31],
that represent a highly conserved subset of ncRNA across species. The majority of miRNAs are transcribed
by RNA polymerase II as primary-miRNA (pri-miRNA) transcripts [32]. Drosha and DGCR8 then cleave
the pri-miRNA into 70 nucleotide stem–loop precursor miRNAs (pre-miRNA) while the RNA is still
in the nucleus [33]. The pre-miRNA is then exported out of the nucleus into the cytoplasm, where it
is cleaved by the Dicer complex [33]. The Dicer complex cleaves the stem–loop into double-stranded
miRNA, which is then loaded onto an AGO protein [34]. The AGO protein unwinds the duplex and loads
the guide strand of the mature miRNA onto the RNA-induced silencing complex (RISC) [34]. This guide
miRNA then guides RISC to the target mRNA [34]. In many instances, one miRNA binds multiple
different mRNAs due to imperfect complementary base pairing to the target sites in the 3’ untranslated
regions [35]. This binding destabilizes the mRNAs and usually results in the degradation of the mRNAs.
In this study, miRNAs were one of the top families of ncRNA identified in the endometrium.
Endometrium on day 11 contained 58 significantly differentially expressed miRNAs. Interestingly,
the majority (54 out of 58) of miRNAs were more highly abundant in samples from non-pregnant
mares. Of the four miRNAs that were more abundant in samples from pregnant mares, all have been
previously described. Eca-mir-8986b has not been identified in equine endometrium, but it is present
in microvesicles secreted from amniotic mesenchymal cells [36]. Microvesicles act as a vehicle for
transport of nucleic acids, lipids, and proteins from cell to cell in a form of communication [37,38].
Eca-mir-1291a has previously been described in the equine epididymis [39]. Beyond this identification,
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eca-mir-1291a has not been identified anywhere else in the body in both horse and other species.
Eca-mir-19a has previously been identified in extracellular vesicles in bovine antral follicles [40].
Mir-19a is also an inhibitor of suppressors of cytokine signaling (SOCS), which inhibit the Janus
kinase–signal transducer and activator of transcription (JAK–STAT) pathway [41–43]. JAK–STAT
signaling mediates cell proliferation and inflammation [44]. While it has not been identified in equine
endometrium, eca-mir-539 is enriched in microvesicles in equine follicular fluid [45]. It is also present
in the equine epididymis [39].
There were 54 miRNAs that were more abundant in endometrial samples from non-pregnant
mares. Out of the 54, 3 had an unknown function and 31 were equivalent to human miRNAs. Those 31
miRNAs were evaluated with DIANAmiR Path to determine KEGG pathways they were targeting [46].
The top pathways protein processing in endoplasmic reticulum, adherens junctions, hippo signaling
pathway, and the cell cycle. Table 2 contains the top 20 processes and their p-values. Supplemental
Table S2 contains all of gene ontology categories targeted.
Table 2. Twenty most significant KEGG Pathways.
KEGG Pathway p-Value
Protein processing in endoplasmic reticulum 1.54E-12
Proteoglycans in cancer 3.66E-12
Adherens junction 1.97E-11
Viral carcinogenesis 1.97E-11
Hippo signaling pathway 2.06E-08
p53 signaling pathway 3.44E-07
Cell cycle 3.74E-07
Renal cell carcinoma 4.62E-07
Pancreatic cancer 1.06E-06
Ubiquitin mediated proteolysis 1.54E-06
Neurotrophin signaling pathway 1.54E-06
TGF-beta signaling pathway 2.25E-06
Prostate cancer 2.25E-06
Epstein–Barr virus infection 2.25E-06
Pathways in cancer 2.25E-06
Glioma 2.77E-06
mRNA surveillance pathway 4.95E-06
Chronic myeloid leukemia 5.02E-06
Hepatitis B 5.02E-06
Endocytosis 6.27E-06
In a previous study, we evaluated serum exosome miRNA content in relation to pregnancy status
and identified differentially expressed miRNAs between samples from pregnant and non-pregnant
mares [19]. We compared those miRNAs to the miRNAs identified in the present study. While the serum
exosome miRNAs are present in the endometrium on either both days (11 and 13) or just day 11 or
day 13, none were significantly more expressed in samples from either pregnant or non-pregnant
mares. This leads to the question of the source of the serum miRNA, and it is undetermined whether
the endometrial miRNAs are from the serum or are the serum exosomal miRNAs from the endometrium.
Another family of ncRNA that was represented in this study was small nuclear RNAs or snRNAs.
They have well-defined functions in mRNA splicing and 3′-end formation [47]. Small nuclear RNAs are
approximately 150 nucleotides in length and are transcribed by RNA polymerase II or III [47]. They are
also components of the spliceosome to participate in pre-mRNA processing [48]. In this study,
snRNAs represented 13 of the significant ncRNA in the endometrium on day 11. Only one of these
ncRNAs were more abundant in samples from pregnant mares, and the remaining 11 were more
abundant in samples from non-pregnant mares. The snRNA that is more abundant in samples
from pregnant mares is in the family of U5 snRNA [49]. U5 snRNAs are involved in both the first
and second catalytic steps in pre-mRNA processing [50]. Of the 12 snRNAs that are more abundant in
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samples from non-pregnant mares, 7 are in the U6 family, 3 are in the U1 family, and 2 are in the U2
family. U6 snRNAs are involved in the 5’ splice site choice [51]. U1 snRNAs function to protect
pre-mRNAs from premature cleavage [52]. These snRNAs may be responsible for the alternative
splicing that was identified in our previous study [12].
The next largest family of ncRNA identified in this study was small nucleolar RNAs,
or snoRNAs. Small nucleolar RNAs are mainly involved in controlling ribosome biogenesis by
guiding the modification or processing of pre-rRNA [53]. There are two main classes of snoRNA,
C/D box and H/ACA box. C/D box snoRNAs are primarily associated with methylation modifications,
and H/ACA box snoRNAs are primarily associated with pseudouridylation [53]. All small nucleolar
RNAs can also be processed into smaller fragments that participate in RNAi [54]. All snoRNAs identified
in this dataset were more abundant in samples from non-pregnant mares. Also identified in this
dataset were scaRNAs (small Cajal body-specific RNA), which are a class of snoRNA. Small Cajal
body-specific RNAs are the modification guide RNAs for spliceosomal snRNAs [55].
In conclusion, this project was the first study to describe the small ncRNA transcriptome in
equine endometrium. There were many novel ncRNA transcripts identified that need to be evaluated
further. While differential expression of ncRNA was identified in samples from day 11, by day 13,
there no transcripts with differential expression between samples from pregnant and non-pregnant
mares. This suggests that by day 13, most mRNA control from ncRNAs associated with MRP may
be concluded. Small RNAs have a robust role in modifying transcription and understanding these
ncRNAs and their targets further could lead to identifying the mechanism for maternal recognition of
pregnancy in the horse.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/10/10/821/s1:
Table S1: All significant ncRNAs (p ≤ 0.05; known and unknown) in equine endometrium from pregnant
and non-pregnant mares on day 11 post-ovulation; Table S2: All Kegg pathways associated with the differentially
expressed miRNA on day 11 that were more abundant in samples from non-pregnant mares.
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